Azurity Pharmaceuticals Showcases Growth and Commercial Momentum ahead of CPHI Milan 2026

Recent approvals and international expansion underscore the company’s evolution as a global specialty pharmaceutical company focused on reimagining medicine for real-world patient needs

Recent approvals and international expansion underscore the company's evolution as a global specialty pharmaceutical company focused on reimagining medicine for real-world patient needs

Go to Source